Blogs
Welcome to Unibest's Blogs section! Here, you will find valuable insights and in-depth reports covering various topics related to drugs and diseases. Our blogs aim to provide an enhanced understanding of the clinical significance and breakthroughs your clients can make. Stay updated with the latest trends, technological advancements, and industry analyses as we dive deep into the world of pharmaceuticals, giving you the knowledge and resources you need to stay ahead of the competition.
  • Case Study of Flow Chemistry in the Synthesis of Pharmaceutical Ingredient Belzutifan

    Case Study of Flow Chemistry in the Synthesis of Pharmaceutical Ingredient Belzutifan

    2024-04-23

    IntroductionIn a previous article, we discussed when to consider using flow chemistry over conventional batch processes for chemical synthesis. One compelling example highlighting the advantages of flow chemistry comes from the manufacturing route development for belzutifan, a recently approved drug Read More
  • Scaling the Everest of Pharma Synthesis: A Deep Dive into Eribulin's Journey

    Scaling the Everest of Pharma Synthesis: A Deep Dive into Eribulin's Journey

    2024-04-19

    As one steps into the realm of pharmaceutical discovery, the name Eribulin, also known as Halaven, rings a powerful note. First approved in 2010 by Eisai, this non-peptide drug, intricate in its synthesis and impressive in the magnitude of its medical impact, has been nothing short of groundbreaking Read More
  • Drug Briefing: Belzutifan

    Drug Briefing: Belzutifan

    2024-04-11

    Query Drug：BelzutifanQuery Time：2024-04-11 13:18:28 Read More
  • Drug Briefing: Midazolam

    Drug Briefing: Midazolam

    2024-04-11

    Query Drug：Midazolam Query Time：2024-04-17 10:20:21 Read More
  • Drug Briefing: Semaglutide

    Drug Briefing: Semaglutide

    2024-04-11

    Query Drug：SemaglutideQuery Time：2024-08-26 09:30:00*** Disclaimer *** The information provided here is sourced from resources such as Drugs.com, the Orange Book, etc., and is auto-generated by the Unibest Digital Center. The content is intended exclusively for pharmaceutical professionals. Unibest Read More
  • The Melt-In-Your-Mouth Medicine

    The Melt-In-Your-Mouth Medicine

    2024-03-01

    Why Choose Orally Dissolving Tablets (ODTs)?Orally dissolving tablets (ODTs) have revolutionized the pharmaceutical industry and patient care by enhancing drug life-cycle management and offering convenient dosing for patients who have difficulty swallowing, such as children, the elderly, and psychia Read More
  • Cancer, radiopharma & RDCs

    Cancer, radiopharma & RDCs

    2024-02-27

    Market potential of radiopharma & RDCsRDCs are currently being developed for cancer. According to the WHO IARC, in 2022, the five most common cancers resulted in 19,956,054 new cases and 9,736,520 deaths. It is estimated that by 2050, the incidence of all cancers will reach 35.3 million. Consequentl Read More
  • Stability of Pharmaceutical Industry Supply Chains Against the Backdrop of Deglobalization

    Stability of Pharmaceutical Industry Supply Chains Against the Backdrop of Deglobalization

    2024-02-23

    In the tide of globalization, supply chains, as the important link connecting the economies of various countries, play an extremely important role. However, in recent years, the trend of deglobalization has gradually emerged, bringing unprecedented challenges to global supply chains. Especially in t Read More
  • Radionuclide Drug Conjugates (RDC): A New Star in Precision Medicine

    Radionuclide Drug Conjugates (RDC): A New Star in Precision Medicine

    2024-02-08

    In today's pharmaceutical industry, an innovative therapeutic known as "Radionuclide Drug Conjugates" (RDC) is gradually making its mark. In the 2023 FDA's approval, there is one drug called flotufolastat F-18 (Posluma). It is an intravenous binder to PSMA expressed on cells for PET imaging of prost Read More
  • Total 12 pages  Go to Page
  • Go